Emma Walmsley - Wikipedia
WEBEmma Walmsley. Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3]
Board of directors and leadership team - GSK
WEBOur board of directors is responsible for corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance. Our Chief Executive Officer is responsible for the management of the business and is assisted by the GSK leadership team (GLT). Each member is responsible for a specific ...
Dame Emma Walmsley - GSK
WEBDame Emma Walmsley | Chief Executive Officer. Emma joined the Board as CEO Designate on 1 January 2017 and became CEO on 1 April 2017. She has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare.
How GSK CEO Emma Walmsley kept her job and turned a
WEBMay 21, 2024 · When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.
Emma Walmsley - Forbes
WEBWalmsley became CEO of GlaxoSmithKline in April of 2017, making her the first woman to run a major pharmaceutical company. In 2023, the U.S. FDA approved Arexvy, GSK's RSV vaccine, for use in the...
GSK boosts CEO Emma Walmsley's pay to £12.7M after strong year
WEBMar 5, 2024 · With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost. Walmsley collected 12.7 million pounds...
Emma Walmsley - GSK | LinkedIn
WEBProud to be leading GSK as we unite science, technology and talent to get ahead of… · Experience: GSK · Education: University of Oxford · Location: London · 1 connection on LinkedIn. View Emma...
- Location: GSK
GSK CEO: AI could fix Big Pharma's R&D inefficiency | Fortune
WEBJun 1, 2023 · GSK CEO Emma Walmsley says A.I. could improve Big Pharma’s most ‘profound’ challenge: R&D productivity. BY Alan Murray and Nicholas Gordon. June 1, 2023, 3:11 AM PDT. Good morning, GSK CEO...
GSK CEO Emma Walmsley: Develop thick skin before moving into …
WEBMay 31, 2023 · On this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram talk with GSK CEO Emma Walmsley about the future of A.I. in the pharmaceutical industry, the...
Emma Walmsley - Stories
WEBEmma Walmsley has been GSK CEO and a member of its board of directors since April 2017. Walmsley has been a member of GSK’s leadership team since 2011, originally as the president and then CEO of GSK Consumer Healthcare.